EGFR and non-small cell lung carcinoma: It has been found that down-regulation of SGLT2 can limit the growth of non-small cell lung cancer (NSCLC) (22), while canagliflozin can induce apoptosis in NSCLC cells harboring the EGFR T790M mutation (23).